Filing Flows › 10x Genomics (TXG) › How it makes money
How 10x Genomics (TXG) makes money
10x Genomics (TXG) made $150M of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. Consumables brought in $134M (89%); Services brought in $9.0M (6%); Instruments brought in $6.9M (5%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Consumables | $134M | 89.4% | +3% | +5% |
| ↳ Single Cell | $93.1M | 62.0% | +5% | +0.7% |
| ↳ Spatial | $41.2M | 27.4% | -3% | +16% |
| Services | $9.0M | 6.0% | -16% | +11% |
| Instruments | $6.9M | 4.6% | -10% | -43% |
| ↳ Single Cell | $3.8M | 2.5% | +23% | -23% |
| ↳ Spatial | $3.1M | 2.0% | -33% | -57% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $150M | 100.0% |
| Income tax | $949K | 0.6% |
| Operating cash flow | $15.8M | 10.5% |
| Free cash flow | $14.9M | 9.9% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $151M | +1% |
| Q2 2026 | $151M | -13% |
| Q1 2026 | $151M | -3% |
| Q4 2025 | $166M | +0.6% |
| Q3 2025 | $149M | -2% |
| Q2 2025 | $173M | +13% |
| Q1 2025 | $155M | +10% |
From 10x Genomics' 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does 10x Genomics make money?
10x Genomics (TXG) made $150M of revenue in the third quarter 2026 (Q3 2026), +1% from a year earlier. Consumables brought in $134M (89%); Services brought in $9.0M (6%); Instruments brought in $6.9M (5%).
What is 10x Genomics' biggest business?
Consumables: $134M in the third quarter 2026, 89% of revenue, +5% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.